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Diabetes mellitus has been reported to be associated with
a significant incidence of gastrointestinal (GI) tract
symptoms, including constipation, nausea, abdominal
pain and diarrhoea (Enck et al. 1994). Studies carried out
in tertiary care centres have shown GI symptoms in
20–60 % of diabetic patients (Feldman & Schiller, 1983;
Clouse & Lustman, 1989), though the prevalence of GI
symptoms in diabetic patients selected from the general
population is much less common (Janatuinen et al. 1993;
Malecki et al. 2000). However, data from several studies
show a weak but significant correlation between GI tract
symptoms and delayed gastric emptying in diabetic
patients (Horowitz et al. 1986, 1991; Wegener et al. 1990).
Although the cause of delayed gastric emptying is not
completely understood, Yamano & colleagues (1997)
surmised that this may be caused by changes in blood
glucose levels, in addition to the autonomic neuropathic
changes known to occur with long-standing diabetes
mellitus (Sampson et al. 1990; Vinik & Suwanwalaikorn,
1997). Indeed, there is evidence from both human and
animal studies indicating that blood glucose level can act
as a modulator of gastric motility (Sakaguchi & Shimojo,
1984; Barnett & Owyang, 1988; Bjornsson et al. 1994).
Animal studies to date have implicated vago-vagal
reflexes in the action of glucose to alter gastric function
(Sakaguchi & Shimojo, 1984; Sakaguchi et al. 1994). These
reflexes consist of three components, the first of which is
a sensory limb comprising chemosensory and mechano-
sensory elements linked to vagal afferent nerves (Rogers
et al. 1995). Data received by these sensory elements are
funnelled via a glutamatergic synapse into the brainstem
at the level of the nucleus of the tractus solitarius (NTS)
(Rogers et al. 1995; Sykes et al. 1997). Many of the
peripheral vagal afferents that synapse in the NTS do so
at the level of the medial subnucleus of the tractus
solitarius (mNTS) (Altschuler et al. 1989). The NTS, in
turn, sends projections to the efferent vagal neurones in
the dorsal motor nucleus of the vagus (DMV), which
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1. To examine the effects of glucose on the central components of the vago-vagal reflex control of
gastric function, we performed both in vivo and in vitro experiments on neurones in the medial
nucleus of the tractus solitarius (mNTS) and in the dorsal motor nucleus of the vagus (DMV). 
2. In the in vivo anaesthetized rat preparation, unilateral microinjection of D-glucose (10 or 50 mM
(60 nl)_1) in mNTS produced inhibition of gastric motility and an increase in intragastric
pressure. D-glucose had no effect in the DMV. 
3. In the in vitro rat brainstem slice preparation, whole-cell recordings of DMV neurones showed
that increasing the glucose concentration of the perfusion solution from 5 mM to 15 or 30 mM
produced outward currents of 35 ± 5 pA (n = 7) and 51 ± 10 pA (n = 11), respectively. These
were blocked by tetrodotoxin and picrotoxin, indicating that glucose was acting indirectly to
cause the release of GABA. Decreasing the glucose concentration of the perfusing solution by
one-half produced an inward current of 36 ± 5 pA (n = 7). 
4. Stimulation of the NTS evoked inhibitory postsynaptic currents (IPSCs) in DMV neurones. The
amplitude of the evoked IPSCs was positively correlated with glucose concentration. Perfusion
with the ATP-sensitive K+ (KATP) channel opener diazoxide mimicked the effect of reduced
glucose, while perfusion with the KATP channel blocker glibenclamide mimicked the effects of
increased glucose. 
5. Our data indicate that glucose had no direct excitatory effect on DMV neurones, but DMV
neurones appear to be affected by an action of glucose on cell bodies of mNTS neurones via
effects on an ATP-sensitive potassium channel.
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project to the parasympathetic ganglia and the enteric
ganglia innervating the digestive tract (Rogers et al.
1995). Most of the projections from the NTS to the DMV
appear to be inhibitory (McCann & Rogers, 1994) and,
although the neurotransmitter released is unknown,
indirect evidence suggests that it is GABA (Feng et al.
1990; Travagli et al. 1991; Washaban et al. 1995; Sivarao
et al. 1998; Browning & Travagli, 1999). 
Glucose exerts pronounced effects both on vagal sensory
nerves and on central components of the reflexes. The
hepatic portal area appears to have glucose sensors linked
to hepatic vagal afferent nerves (Sakaguchi & Shimojo,
1984; Sakaguchi et al. 1994). In fact, glucose administered
into the hepatic portal vein has been reported to decrease
hepatic vagal afferent discharge rate (Niijima, 1969;
Niijima & Mequid, 1994). Neurones in both NTS and DMV
have also been shown to be affected by glucose. Glucose
injected into the DMV of anaesthetized rats has been
shown to decrease gastric motility and intragastric
pressure (Sakaguchi et al. 1985, 1994). Conversely, gastric
motility or pressure did not seem to be affected when
glucose was injected into the NTS, although additional
studies indicated that glucose injected into the NTS could
reduce gastric acid secretion (Sakaguchi & Sato, 1987). 
Electrophysiological studies of these two brainstem nuclei
indicate the presence of both glucoresponsive (i.e. gluco-
excitatory) and glucosensitive (i.e. gluco-inhibitory)
neurones (Mizuno & Oomura, 1984; Adachi et al. 1995),
and, in the case of the NTS, the majority of the gluco-
responsive neurones were shown to be linked to the KATP
channel (Dallaporta et al. 2000).
The purpose of the present study was to evaluate the
potential role of each of these brainstem nuclei in the
effects of glucose to modulate vagal control of gastric
motility and tone. This was accomplished using two
complementary approaches, namely, microinjection of
glucose into the mNTS and the DMV of the anaesthetized
rat while monitoring intragastric pressure and motility,
and patch-clamp analysis of electrical activity of DMV
neurones exposed to different concentrations of glucose.
A preliminary account of this paper has been presented
previously (29th Annual Meeting of the Society for
Neuroscience, 1999).
METHODS
In vivo rat studies
Animal preparation. Experiments were performed on male
Sprague-Dawley rats (n = 59) weighing 250–350 g (Taconic,
Germantown, NY, USA). Prior to each experiment, food was
withheld overnight but water was provided ad libitum. Animals were
anaesthetized with an intraperitoneal injection of a cocktail
(3 ml kg_1) containing urethane (800 mg kg_1) and a-chloralose
(60 mg kg_1) dissolved in 3 ml of 0.9 % saline. Body temperature was
monitored by a rectal thermometer and maintained at 37 ± 1 °C with
an infrared heating lamp. Before surgery, all animals were
pretreated with dexamethasone (0.8 mg, subcutaneously) to
minimize brain swelling. Animal care and experimental procedures
were performed in accordance with the NIH guidelines and with the
approval of the Animal Care and Utilization Committee of
Georgetown University, Washington, DC, USA. 
Surgery. Rats were intubated to maintain an open airway and for
instituting artificial respiration when necessary. The carotid artery
was cannulated with polyethylene tubing (PE 50) to monitor blood
pressure. Blood pressure was recorded using a bridge amplifier
connected to a MacLab (ADInstruments, Milford, MA, USA) data
acquisition system. Data were stored on computer (Apple Macintosh
G3 connected to MacLab) for analysis at a later time. In some
animals, ligatures were placed around the vagus nerves and were
tied, to be avulsed at a later time. For each experiment an intra-
gastric balloon, made from the little finger of a small latex glove, was
tied around polyethylene tubing (PE 160) and was inserted into the
stomach via the fundus. The tubing was connected to a pressure
transducer, which was connected to a bridge amplifier (MacLab).
Data were saved for analysis at a later time. The stomach was
inflated by introducing warm saline (2–3 ml) into the balloon, to
achieve a baseline pressure of 6–15 mmHg. The animals were then
positioned in a stereotaxic apparatus (David Kopf, Tujunga, CA,
USA). A partial dorsal craniotomy was performed to expose the
fourth ventricle. The cerebellum was retracted slightly while using a
26 gauge needle to cut the subarachnoid covering. Calamus
scriptorius (cs) was viewed from the dorsal aspect and used as a point
of reference (see below). 
Microinjection technique. D-Glucose was dissolved in 0.9 % saline. A
histological marker (Fast Green dye) for locating injection sites was
added to drug solutions in a 1–2 mg ml_1 concentration. The pH of all
drug solutions was brought to 7.0–7.2. Double-barrelled pipettes
with a tip diameter of between 30 and 60 µm were used. All micro-
injections were given unilaterally. Injections were given in volumes
of 60 nl and administered by hand-controlled pressure. Micro-
injections were given within 5 s. Calamus scriptorius was used as a
zero reference point. Stereotaxic co-ordinates were originally chosen
based on histology in Paxinos & Watson (1986). Co-ordinates for the
DMV ranged from 0.3–0.5 mm rostral to cs, medial–lateral
0.3–0.5 mm lateral from the midline, and dorsal–ventral
0.5–0.7 mm from the dorsal surface of the medulla. Co-ordinates for
the mNTS ranged from 0.3–0.5 mm rostral to cs, 0.5–0.7 mm lateral
from the midline, and from 0.4–0.6 mm from the dorsal surface of
the medulla. These co-ordinates were chosen based on co-ordinates
developed in our earlier published study of nicotine (Ferreira et al.
2000). 
Histologic verification. At the end of the experiment all rats were
killed with an overdose of pentobarbital. Brains were removed and
fixed in a mixture of 4 % paraformaldehyde and 20 % sucrose for at
least 24 h. The brain was cut into 50 µm thick coronal sections and
stained with Neutral Red. The location of nuclear groups was studied
in relation to microinjection sites using the atlas of Paxinos & Watson
(1986).
Data analysis. Data were analysed using the Chart Software for
data analysis made for MacLab (ADInstruments). Before micro-
injections were performed, the lowest points of the intragastric
pressure (IGP) trace were obtained over a 5 min control period, and a
single value was calculated as the mean of all of these points and used
as an index of gastric tone. After microinjections into the mNTS, the
maximum value in the trace was taken as the largest increase in
gastric tone. The percentage change from baseline in IGP was then
calculated. Data for IGP are reported as percentage change from
baseline since baseline IGP varied between animals. It should be
noted that all data that are shown to be statistically significant are
significant when analysed both as raw data and as percentage change
from baseline. Data appear as means (percentage change from
baseline for IGP) ±S.E.M. To calculate the area under the curve for the
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phasic contractions appearing in the IGP traces, the MacLab data
analysis package was utilized. The program calculates the area under
the curve as an integral that is represented by:
∑(y _ y Baseline(t)) w ∆t, 
where y _ y Baseline denotes the first and last data point in the
selection and ∆t is the sample interval (5 min in our study). Student’s
paired t tests were performed in all cases as animals served as their
own controls. Differences were considered significant at P < 0.05.
In vitro brain slice studies 
Gastric-projecting DMV neurones were labelled as described
previously (Browning et al. 1999). Briefly, 12-day-old rat pups of
either sex were anaesthetized deeply (indicated by abolition of the
foot-pinch withdrawal reflex) with a 6 % solution of 2-bromo-
2-chloro-1,1,1-trifluoroethane (Halothane) with air (400–600 ml
min_1) before an abdominal laparotomy was performed. During
surgery anaesthesia was maintained by placing the head of the rat in
a custom-made anaesthetic chamber through which the halothane
mixture was perfused. Crystals of the retrograde tracer Dil were
applied to the serosal surface of the gastric fundus, corpus or the
antrum/pylorus. The application site was embedded in a fast-
hardening epoxy resin that was allowed to dry for several minutes
before the entire surgical area was washed with warm saline. The
wound was closed with 5/0 silk suture and the animal allowed to
recover for 10–15 days.
The brainstems were removed as described previously (Travagli et al.
1991; Browning et al. 1999). Briefly, the rats were placed in an
anaesthetic chamber and anaesthetized with halothane before being
killed by severing the major blood vessels in the chest. The brainstem
was removed and placed in oxygenated Krebs solution at 4 °C (see
below for composition). Using a vibratome, six to eight coronal
sections (200 µm thick) containing the dorsal vagal complex were cut
and stored in oxygenated Krebs solution at 30 °C for at least 1 h prior
to use. A single slice was transferred to a custom-made perfusion
chamber (volume 500 µl) and kept in place using a nylon mesh. The
chamber was maintained at 35 °C by perfusion with warmed,
oxygenated Krebs solution at a rate of 2.5–3.0 ml min_1.
Prior to electrophysiological recording, gastric-projecting DMV
neurones were identified using a Nikon E600-FS microscope
equipped with epifluorescence filters suitable for visualizing Dil.
Once the identity of a labelled neurone was confirmed, whole-cell
recordings were made under brightfield illumination.
Electrophysiological recording. Whole-cell recordings were made
with patch pipettes (3–8 MΩ resistance) filled with a potassium
gluconate solution (see below for composition) using an Axopatch ID
single electrode voltage-clamp amplifier (Axon Instruments, Foster
City, CA, USA). Perforated-patch recordings were made using
pipettes (3–8 MΩ resistance) filled with a potassium gluconate
solution containing gramicidin (see below for composition and
Spruston & Johnston (1992) for detailed technique). 
Recordings were made from neurones unequivocally labelled with
Dil. Data were filtered at 2 kHz, digitized via a Digidata 1200C
interface (Axon Instruments), acquired, stored and analysed on an
IBM PC utilizing pCLAMP 8 software. Recordings were accepted
only if the series resistance (i.e. pipette + access resistance) was
< 15 MΩ. In addition, the neuronal membrane had to be stable at the
holding potential, the action potential evoked following injection of
depolarizing current had to have an amplitude of at least 60 mV and
the membrane potential had to return to the baseline value following
the action potential after-hyperpolarization.
Electrical stimulation. Bipolar tungsten electrodes were used to
electrically stimulate the centralis and medialis subnuclei of the NTS.
Paired stimuli (0.1–1.0 ms, 10–500 µA; 50–300 ms interval) were
applied every 20 s to evoke submaximal excitatory (EPSCs) or
inhibitory (IPSCs) postsynaptic currents. 
All experiments involving evoked IPSCs were carried out in the
presence of 1 mM kynurenic acid (to eliminate spontaneous and
evoked EPSCs) and with 0.5 mM QX314 in the internal pipette
solution (to eliminate antidromically evoked action potentials).
QX314, 0.5 mM, was also used in the internal pipette in experiments
involving evoked EPSCs. A minimum of six control EPSCs or IPSCs
were obtained prior to each drug application. Drugs were applied to
the bath via a series of manually operated valves. To assess the
effects of drugs, each neurone served as its own control (i.e. the
results obtained after administration of a drug were compared to
those before administration using Student’s paired t test). Results are
expressed as means ± S.E.M. Significance was set at P < 0.05.
Drugs and solutions. Materials used for the in vivo rat studies were
as follows: D-glucose, L-glucose, urethane, a-chloralose, Fast Green
dye and dexamethasone. All were purchased from Sigma Chemical
Co. (St Louis, MO, USA) except dexamethasone which was purchased
from Elkins-Sinn (Cherry Hill, NJ, USA). 
Materials used for the in vitro studies were as follows: extracellular
solution materials (Krebs solution) (mM): NaCl, 126; NaHCO3, 25;
KCl, 2.5; MgCl2, 1.2; CaCl2, 2.4; NaH2PO4, 1.2; and glucose, 5;
maintained at pH 7.4 by bubbling with 95 % O2–5 % CO2. Equi-molar
Krebs solutions were prepared by either substituting sodium chloride
for glucose (as in the case of 2.5 mM solution) or vice versa (as in the
case of 11, 15 and 30 mM solutions).
Intracellular solution materials (mM): potassium gluconate, 128; KCl,
10; CaCl2, 0.3; MgCl2, 1; Hepes, 1; EGTA, 1; ATP, 2; and GTP, 0.25;
adjusted to pH 7.35 with KOH.
Intracellular solution materials for perforated patch (mM): potassium
gluconate, 128; KCl, 10; CaCl2, 0.3; MgCl2, 1; Hepes, 1; and EGTA, 1;
with 100 µg ml_1 gramicidin, adjusted to pH 7.35 with KOH.
1,1fi-Dioctadecyl-3,3,3fi,3fi-tetramethylindocarbocyanine perchlorate
(DilC18(3); Dil) was purchased from Molecular Probes (Eugene, OR,
USA). 2-Bromo-2-chloro-1,1,1-trifluoroethane (Halothane) and all
other materials listed for the composition of the solutions were
purchased from Sigma Chemical Co.
RESULTS
In vivo studies
Gastric motility was decreased and intragastric
pressure was increased by microinjection of D-glucose
in the mNTS but not in the DMV
Unilateral microinjections of D-glucose (60 nl of a 10 mM
solution) into the DMV were performed in eight
anaesthetized rats while monitoring intragastric pressure
and motility. We did not observe any effect on either
intragastric pressure or gastric motility in any of the
experiments (Figs 1 and 2). In three experiments,
D-glucose (60 nl of a 50 mM solution) was tested by
unilateral microinjection into the DMV. Again, no effect
of D-glucose on gastric function was observed (Fig. 2).
Finally, to provide a more sensitive endpoint (i.e. a higher
level of baseline gastric motility) for detecting an
inhibitory effect of D-glucose microinjected into the
DMV, we administered insulin (5 units) subcutaneously in
three animals prior to unilateral microinjection of 60 nl of
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a 10 mM solution of D-glucose into the DMV. Despite the
increase in gastric motility produced by insulin-induced
hypoglycaemia, unilateral microinjection of D-glucose
into the DMV had no effect on gastric motility (data not
shown). The sites in the dorsomedial medulla where
D-glucose was microinjected in the experiments described
above are depicted in Fig. 3. As can be noted, all sites were
located within the confines of the DMV. 
Contrary to the lack of effect of microinjections of
D-glucose into the DMV, unilateral microinjection of 60 nl
of a 10 mM solution of D-glucose into the mNTS produced
inhibition of gastric motility with an immediate onset,
but a relatively slow developing increase in intragastric
pressure (n = 5; Figs 2 and 4). These effects dissipated
over a period of 15–30 min but could be reproduced in the
same experiment by repeated microinjection of 60 nl of a
10 mM D-glucose solution (data not shown). When 60 nl of
a 50 mM solution of D-glucose was microinjected
unilaterally into the mNTS (n = 5), the effect on motility
and intragastric pressure appeared to be intensified
(Fig. 2). Three types of control experiments were
performed. First, D-glucose (60 nl of a 10 mM solution)
was microinjected into sites outside the mNTS (Fig. 3).
These microinjections did not produce an effect on
motility or on intragastric pressure (data not shown). The
other two types of controls were microinjection of either
60 nl of 0.9 % saline solution or 60 nl of a 10 mM L-glucose
solution into the mNTS or DMV (Fig. 3). When 10 mM
L-glucose was microinjected into the mNTS, a 2.7 ± 1.5 %
change in intragastric pressure (n = 5; P > 0.05) and a
_52 ± 49 mmHg s_1 change in the area under the curve
(n = 4; P > 0.05) occurred. When 10 mM L-glucose was
microinjected into the DMV, a 1.2 ± 0.7 % change in
intragastric pressure (n = 3; P > 0.05) and a _36 ±
24 mmHg s_1 change in the area under the curve (n = 3;
P > 0.05) occurred. There was no significant difference
between the responses elicited by saline or L-glucose
microinjected into these nuclei, ruling out the possible role
of injectate osmolarity in the response of D-glucose. In no
case did these control microinjections affect motility or
intragastric pressure (Fig. 2). 
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Figure 2. Effects of D-glucose microinjected into
the DMV and mNTS on intragastric pressure
(IGP) and the area under the curve (i.e. area of
phasic antral contractions) 
A, percentage change of IGP due to microinjection of
saline (designated as 0 glucose), 10 and 50 mM (in
60 nl) D-glucose into the DMV (5), and the response
due to microinjection of saline (designated as
0 glucose), 10 and 50 mM (in 60 nl) D-glucose into the
mNTS (4). B, change of the area under the curve
(mmHg s_1) in response to microinjection of saline
(designated as 0 glucose), 10 and 50 mM (in 60 nl)
D-glucose into the DMV (5), and microinjection of
saline (designated as 0 glucose), 10 and 50 mM (in
60 nl) D-glucose into the mNTS (4). IGP data are
represented as the means ± S.E.M. of 3–6
microinjection sequences. Change in the area under
the curve data are represented as the means ± S.E.M.
of 3 or 4 microinjection sequences. * P < 0.05 using
Student’s group t test.
Figure 1
Effect of unilateral microinjection of D-glucose (60 nl
of 10 mM solution) into the DMV on intragastric
pressure and gastric motility (see text for details).
Ipsilateral vagotomy had no effect on either the
inhibition of gastric motility or the increase in intragastric
pressure induced by D-glucose (n = 4; Table 1). Bilateral
cervical vagotomy, however, prevented D-glucose from
producing an increase in IGP (n = 4; Table 1). We were
not able to evaluate bilateral cervical vagotomy on phasic
contractions because sectioning both cervical vagus
nerves per se abolished all phasic contractions (Table 1).
The lack of effect of ipsilateral vagotomy and the
requirement for bilateral vagotomy for abolishing
responses evoked from the mNTS was noted before
(Ferreira et al. 2000), and is due to the fact that neurones
of the mNTS connect to both the right and left DMVs
(Blessing et al. 1991). Finally, the sites in the dorsomedial
medulla where D-glucose was microinjected in the
experiments described above are depicted in Fig. 3. As
can be noted, all sites were located within the confines of
the mNTS.
In vitro studies
Postsynaptic effects: increasing the extracellular
glucose concentration induced an outward current in
DMV neurones
Whole-cell recordings. Whole-cell patch clamp recordings
were made from 77 identified gastric-projecting neurones
(35 fundus, 22 corpus and 20 antrum/pylorus-projecting
neurones). In 75 of these neurones, the glucose
concentration was raised from 5 to 11 mM (n = 8), 15 mM
(n = 28) or 30 mM (n = 49) (note: some neurones were
exposed to more than one concentration of glucose).
Twenty-nine neurones (38 %) responded with an outward
current, 1 neurone (1 %) responded with an inward
current with the remaining 47 neurones (61 %) showing
no effect. 
The magnitude of the outward current was 12 ± 1.5 pA
(n = 4), 36 ± 4.6 pA (n = 7) and 51 ± 9.7 pA (n = 11)
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Figure 3. Microinjection sites for D-glucose and
control studies
Two camera lucida drawings of coronal sections of the
medulla are depicted to illustrate the location of the
pipette tips indicating the microinjection sites of
D-glucose (w), D-glucose controls (0) and L-glucose or
saline (1). Microinjection sites (tip of micropipette)
were located in these two rostral–caudal areas of the
medulla, namely at obex, and slightly caudal to obex
(i.e. 0.2 mm caudal to obex). For clarity, all mNTS
injection sites are shown on the left and DMV sites
are shown on the right. mNTS, medial nucleus of the
tractus solitarius; TS, tractus solitarius; CC, central
canal; DMV, dorsal motor nucleus of the vagus; XII,
hypoglossal; AP, area postrema.
Figure 4 
Effect of unilateral microinjection of D-glucose (60 nl
of 10 mM solution) into the mNTS on intragastric
pressure and gastric motility (see text for details).
Figure 5. Superfusion with 30 mM glucose
induced an outward current that was sensitive to
tetrodotoxin and picrotoxin
Representative traces of gastric-projecting DMV
neurones voltage clamped at _50 mV showing that
elevating the glucose concentration of the
superfusing Krebs solution from 5 to 30 mM induced
an outward current (current allowed to plateau, then
wash was performed so that the current could return
to baseline levels, typically after 10 min) that was
inhibited by the synaptic blocker tetrodotoxin
(incubation of 10 min; 1 µM, A) as well as by the
GABAA receptor channel-selective antagonist
picrotoxin (50 µM, B). 
when glucose was raised from 5 mM to 11, 15 and 30 mM,
respectively (Fig. 5). Concentrations above 30 mM glucose
Krebs solution were not tested. In 19 neurones, the
effects of a decrease in glucose concentration (from 5 to
2.5 mM) were assessed. Seven of these neurones (37 %)
responded with an inward current of 35 ± 5 pA amplitude
with the remaining 12 neurones (63 %) displaying no effect.
The glucose-induced outward current in DMV
neurones was due to an indirect effect of glucose. As
in the case of the in vivo studies, the in vitro brain slice
studies also indicated no evidence for a direct effect of
D-glucose on DMV neurones. In fact, in the presence of
the synaptic transmission blocker tetrodotoxin (TTX,
1 µM), the outward current induced by increasing the
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Figure 6. Elevated glucose concentration increased evoked excitatory synaptic current (EPSC)
amplitude via actions at a presynaptic site 
A, representative traces showing that application of paired stimuli (85 ms apart) to the NTS induced
EPSCs in the recorded gastric-projecting DMV neurone. Increasing the concentration of glucose in the
superfusing Krebs solution from 5 to 15 mM increased the amplitude of the evoked EPSCs. Normalization
of the amplitudes of the first EPSCs (C1) revealed that the ratio of the paired currents (C2:C1) was altered.
B, the presynaptic excitatory action of an increase in glucose concentration was mimicked by the ATP-
sensitive potassium channel blocker glibenclamide (10 µM). C, summary histogram illustrating the
alteration in the ratio of the paired EPSCs (C2:C1) following an increase in the glucose concentration of
the superfusing Krebs solution or application of glibenclamide, indicating that such effects occurred
presynaptically. *P < 0.05.
Table 1. Effects of vagotomy on glucose-induced (10 mM (60 nl)–1) changes in
intragastric pressure and phasic activity evoked from the mNTS
Post-
Pre-Vx ipsilateral Vx Bilateral Vx
IGP +7.9 ± 0.4 +8.2 ± 1.1 +0.9 ± 0.3*
Phasic _439 ± 78.0 _397 ± 64.0 Phasic activity was 
absent and no response
to D-glucose was observed
Values represent means ± S.E.M. (n = 4). Intragastric pressure (IGP) is expressed as percentage change
from baseline and phasic activity is in mmHg s_1. Vx, vagotomy. *P < 0.05 using ANOVA followed by
Duncan’s test. Baseline values: IGP, 12.4 ± 3.6 mmHg and Phasic, 470 ± 90 mmHg s_1.
glucose concentration to 30 mM was decreased from
61 ± 17.0 pA in control to 8 ± 1.6 pA in the presence of
TTX (i.e. an 84 ± 6 % reduction; n = 6, P < 0.05; Fig. 5).
Similarly, in the presence of picrotoxin (50 µM), a
selective blocker of the GABAA-gated chloride channel,
the outward current induced by 30 mM glucose was
reduced from 38 ± 3.1 pA in control to 4 ± 2.0 pA in the
presence of picrotoxin (i.e. an 89 ± 5 % reduction; n = 5,
P < 0.05; Fig. 5). 
Perforated-patch recordings. To circumvent the need
to include ATP within the patch pipette solution and
avoid any potential problems of unwittingly closing
ATP-sensitive potassium channels, recordings were also
made from gastric-projecting DMV neurones using the
perforated-patch technique. Gramicidin (100 µg ml_1)
perforated-patch recordings were made from 17 gastric-
projecting neurones. Of these, four (24 %) responded to an
elevation of glucose concentration from 5 to 30 mM with
an outward current of 47 ± 5 pA that did not differ
significantly from the outward current induced by the
same increase in glucose concentration in cells recorded
with the whole-cell patch clamp method (P > 0.05). In
addition, as with the whole-cell patch clamp technique,
the outward currents observed with the perforated-patch
technique were reduced by 72.4 % following exposure to
TTX (1 µM; n = 2) and by 91 % following superfusion
with picrotoxin (50 µM; n = 2).
Presynaptic effects: increasing the extracellular
glucose concentration increased the amplitude of
electrically evoked currents
In 34 neurones, the effects of altered extracellular glucose
concentrations were assessed on the amplitudes of IPSCs
and EPSCs evoked by stimulation of the NTS. In five
neurones, increasing extracellular glucose levels from 5 to
11 mM increased the evoked IPSC amplitude from
165 ± 23 pA to 207 ± 21 pA (i.e. 130 ± 14 % of control;
P < 0.05). Similarly, increasing extracellular glucose
levels from 5 to 15 mM or to 30 mM also increased the
evoked IPSC amplitudes from 254 ± 57 pA to
313 ± 66 pA and from 218 ± 51 pA to 276 ± 64 pA,
respectively (n = 5 for both, P < 0.05). In each case, the
ratio of the peak amplitude of the evoked currents
(paired-pulse ratio) was altered suggesting a presynaptic
site of action (Trombley & Westbrook, 1990; Travagli &
Glucose effects in dorsal vagal complexJ. Physiol. 536.1 147
Figure 7. Reduced glucose concentration decreased evoked inhibitory synaptic current (IPSC)
amplitude via actions at a presynaptic site
A, representative traces showing that application of paired stimuli (150 ms apart) to the NTS induced
IPSCs in the recorded gastric-projecting DMV neurone. Decreasing the concentration of the superfusing
Krebs solution from 5 to 2.5 mM reduced the amplitude of the evoked IPSCs. Normalization of the
amplitudes of the first IPSCs (C1) revealed that the ratio of the paired currents (C2:C1) was altered. B, the
presynaptic inhibitory action of a decrease in glucose concentration was mimicked by the ATP-sensitive
potassium channel opener diazoxide (300 µM). C, summary histogram illustrating the alteration in the
ratio of the paired IPSCs (C2:C1) following a decrease in the glucose concentration of the superfusing
Krebs solution or application of diazoxide. *P < 0.05.
Williams, 1996; Bertolino et al. 1997; Browning &
Travagli, 1999). For example, elevating glucose levels
from 5 to 15 mM increased the paired-pulse ratio from
0.76 ± 0.13 to 0.83 ± 0.14 (P < 0.05).
This presynaptic site of action was confirmed by use of
the GABAA-receptor agonist muscimol (100 µM), applied
by pressure ejection, to evoke an outward current in the
recorded neurone. The amplitude of the muscimol-evoked
outward current was not affected by increasing the
extracellular glucose concentration from 5 to 15 mM: the
muscimol-induced current was 443 ± 77 pA in 5 mM
glucose and 452 ± 71 pA in 15 mM glucose (n = 5;
P > 0.05).
Elevated extracellular glucose concentrations had similar
effects on evoked EPSC amplitudes. Specifically, in five
neurones, increasing the extracellular glucose concentration
from 5 to 11 mM increased the amplitude of evoked
EPSCs from 241 ± 34 to 287 ± 26 pA (i.e. 123 ± 12 % of
control; P < 0.05). Elevating the glucose concentration
from 5 to 15 mM increased evoked EPSC amplitude from
134 ± 18 to 170 ± 22 pA (i.e. 128 % of control; n = 5,
P < 0.05; Fig. 6). Similarly, elevating the extracellular
glucose concentration from 5 to 30 mM increased
evoked EPSC amplitude from 224 ± 59 to 288 ± 61 pA
(i.e. 136 % of control; n = 5, P < 0.05). In each instance,
the ratio of the paired current amplitudes was altered,
suggesting a presynaptic site of action. For example,
increasing glucose concentration from 5 to 15 mM
increased the paired-pulse ratio from 0.82 ± 0.04 to
1.06 ± 0.18 (P < 0.05; Fig. 6). 
The ATP-sensitive potassium channel blocker
glibenclamide (10 µM) mimicked the actions of elevated
glucose concentrations on synaptic transmission. Gliben-
clamide increased the amplitude of evoked EPSCs from
219 ± 61 to 268 ± 65 pA (n = 6; P < 0.05; Fig. 6), while
in a further five neurones, glibenclamide increased the
amplitude of evoked IPSCs from 188 ± 19 to 221 ± 24 pA
(n = 5; P < 0.05). In both instances, glibenclamide altered
the paired-pulse ratio again suggesting a presynaptic site
of action. Specifically, glibenclamide increased the
paired-pulse ratio of evoked IPSCs from 0.54 ± 0.17 to
0.60 ± 0.16 (P < 0.05) while the paired-pulse ratio of
evoked EPSCs was decreased from 0.89 ± 0.14 to
0.75 ± 0.13 (P < 0.05; Fig. 6). 
Presynaptic effects: decreasing the extracellular
glucose concentration decreased the amplitude of
electrically evoked currents
In five neurones, lowering the glucose concentration from
5 to 2.5 mM reduced the amplitude of evoked IPSCs to
77 ± 2 % of control (from 245 ± 43 to 189 ± 31 pA;
P < 0.05; Fig. 7). The ratio of the amplitude of the paired
evoked currents was increased from 0.87 ± 0.03 to
0.90 ± 0.06 (P < 0.05; Fig. 7) indicating that the effect
was presynaptic in nature. 
This presynaptic site of action was confirmed by use of
the GABAA receptor agonist muscimol (100 µM), applied
by pressure ejection, to evoke an outward current in the
recorded neurone. The amplitude of the muscimol-evoked
outward current was not affected by decreasing the
extracellular glucose concentration from 5 to 2.5 mM. The
muscimol-induced current was 539 ± 85 pA in 5 mM
glucose and 540 ± 75 pA in 2.5 mM glucose (n = 4;
P > 0.05).
The action of lowered glucose concentration to reduce the
amplitude of evoked IPSCs was mimicked by the ATP-
sensitive potassium channel opener diazoxide (300 µM).
Specifically, in five neurones, superfusion with diazoxide
reduced the amplitude of evoked IPSCs from 231 ± 50 to
198 ± 50 pA (i.e. to 84 ± 5 % of control; P < 0.05; Fig. 7).
Diazoxide also increased the paired-pulse ratio from
0.79 ± 0.12 to 0.86 ± 0.07 (P < 0.05; Fig. 7) suggesting a
presynaptic site of action. 
Similarly, in five neurones, lowering the glucose
concentration from 5 to 2.5 mM reduced the amplitude
of evoked EPSCs from 222 ± 78 to 183 ± 70 pA
(i.e. 79 ± 4 % of control; P < 0.05). The ratio of the
amplitude of the paired evoked currents was increased
from 0.88 ± 0.14 to 1.06 ± 0.17 (P < 0.05) indicating that
the effect was presynaptic in nature. The actions of
lowered glucose concentration to reduce the amplitude of
evoked EPSCs was mimicked by diazoxide (300 µM).
Specifically, in five neurones, superfusion with diazoxide
reduced the amplitude of evoked EPSCs from 261 ± 75
to 211 ± 76 pA (i.e. 76 ± 1 % of control; P < 0.05).
Diazoxide also increased the paired-pulse ratio from
0.98 ± 0.15 to 1.19 ± 0.19 (P < 0.05), suggesting a
presynaptic site of action.
DISCUSSION
The results of the present study indicate that acute
hyperglycaemia affects the vagal brainstem neuro-
circuitry controlling gastric function, primarily via
actions on the synaptic connections between the mNTS
and the DMV. A summary of our evidence is as follows: (i)
microinjection of D-glucose into the mNTS inhibited
gastric motility and increased gastric tone; (ii) micro-
injection of the same doses of D-glucose into the DMV of
anaesthetized rats had no effect on either gastric motility
or intragastric pressure; (iii) whole-cell recordings in
identified gastric-projecting DMV neurones revealed no
direct effect of acute hyperglycemia; and (iv) increasing
the glucose concentration increased the amplitude of
synaptic currents evoked from the NTS. 
Although we do not have sufficient evidence to conclude
that all the effects of hyperglycaemia were due to glucose
actions on mNTS neurones, our in vivo data obtained
following microinjection of glucose into the mNTS
suggest that the mNTS is a strong candidate for the site
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where glucose-evoked changes are occurring. The data
obtained from the in vitro experiments further support
this suggestion (see below). 
In vivo experiments
The starting point in these studies was to assess whether
microinjection of D-glucose into the DMV of anaesthetized
rats would decrease intragastric pressure and inhibit
gastric motility. Our rationale for pursuing these
experiments was based on the findings of Sakaguchi &
colleagues, who reported that microinjection of D-glucose
into the DMV can depress gastric motility of rats
(Sakaguchi et al. 1985, 1994).
Our data confirm that acute hyperglycaemia produces
robust effects to decrease gastric motility and increase
gastric tone, but in addition indicate, for the first time,
that these effects are due to exposure of mNTS and not
DMV neurones to elevated glucose concentrations.
Our data are in contrast with previous reports that
suggested that the DMV is a brainstem site at which
glucose acts to inhibit gastric function (Sakaguchi et al.
1985). Their evidence was obtained using much higher
concentrations of glucose than those tested in the present
study (e.g. 10 and 50 mM in the current study as
compared to 138, 277 and 555 mM in their study).
Furthermore, Sakaguchi et al. (1985) microinjected
volumes of glucose ranging from 500 to 1000 nl, as
compared to the 60 nl volume used in the present study.
Volumes this large microinjected into the DMV, in our
opinion, are very likely to affect nearby structures such
as the NTS. Finally, the gastric response noted by
Sakaguchi et al. (1985) was a glucose-induced decrease in
intragastric pressure. We observed the opposite response
with glucose microinjected into the mNTS, namely, an
increase in intragastric pressure. In a subsequent study by
this group, Sakaguchi et al. (1994) reported that 500 nl of
4 mM glucose injected into the DMV of rats reduced
gastric motility as reflected by a downward shift in the
power spectrum for motility but no effect of this dose of
glucose was noted following injection into the NTS.
Similarly, 500 nl of 10 mM glucose injected into the DMV
of rats decreased gastric pressure. Finally, Sakaguchi et
al. (1994) showed that injection of 500 nl of a 7.5 and a
10 mM glucose solution into the DMV of rats decreased the
intensity area of motility. This latter endpoint of gastric
function is analogous to our measurement of gastric
motility. In our study, 60 nl of neither a 10 mM nor a
50 mM glucose solution microinjected into the DMV had
any effect on gastric motility. The reason(s) for the
observed differences between the results of Sakaguchi et
al. (1994) and our own findings is unclear, though we
surmise that our microinjection technique may have
allowed more precise localization of glucose effects to the
mNTS and the DMV by virtue of the much smaller
injection volumes. In support of this, in a recent report we
showed that microinjections of drugs in the same volume
as that used in the present study provided functional
responses that could, in fact, be attributed to discrete
activation of either mNTS or DMV (Ferreira et al. 2000;
Ferreira, 2000). 
In addition, the involvement of GABAergic neurones
that project from the NTS to DMV in the control of
gastric functions has been well established. Microinjection
of the GABAA antagonist bicuculline into the DMV has
been reported to produce a pronounced effect on gastric
mechanical function (Sivarao et al. 1998; Ferreira, 2000),
and in the present study we have shown that GABA-
mediated currents occur in DMV neurones upon exposure
to elevated glucose levels. That NTS neurones are excited
by elevated glucose levels has also been shown by several
investigators using in vitro preparations (Mizuno &
Oomura, 1984; Adachi et al. 1995; Yettefti et al. 1995;
Dellaporta et al. 1999, 2000). Based on the accumulated
evidence for the involvement of GABAergic neurones
projecting from the NTS to the DMV, we postulate that
GABA-mediated effects on DMV neurones lead to
reduced excitatory input to the stomach and this is
reflected by inhibition of phasic activity in the antrum.
The explanation for the observed increase in gastric tone,
on the other hand, is unclear. In an attempt to elucidate
the mechanism, a few experiments were performed in
vitro wherein glucose was tested on DMV neurones
projecting to the antrum and to the fundus (retrograde
tracer was applied to these gastric sites several days prior
to performing patch clamp recordings). Our purpose was
to determine whether glucose would exert differing
effects on antral-projecting vs. fundus-projecting neurones.
In these preliminary studies no difference in the effect of
glucose on antral- and fundus-projecting neurones was
noted. Another possible explanation for why gastric tone
increased is that a withdrawal of the gastric relaxation
provided by an increased inhibition of non-adrenergic
non-cholinergic vagal pathways (Krowicki & Hornby,
1996) had occurred, as a result of an increased GABAergic
tone from the mNTS to the DMV. 
In vitro experiments
In the in vitro experiments, hyperglycaemia produced an
outward current in DMV neurones that was antagonized
by the synaptic blocker tetrodotoxin and by the GABA
receptor channel blocker picrotoxin. Thus, we concluded
that glucose may be acting on an afferent input to the
DMV to release GABA. Indeed, hyperglycaemia increased
the amplitude of synaptic currents evoked by electrical
stimulation of the NTS, and our data suggest that this
effect was presynaptic. Thus, the response of gastric-
projecting DMV cells to direct application of the GABAA-
selective agonist muscimol was unaffected by variations
of the extracellular glucose concentration; and the paired-
pulse ratio was altered following hyperglycaemia. 
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In addition, acute hypoglycaemia also produced
significant effects on the central component of the vago-
vagal reflex. The in vitro whole-cell recordings indicated
the occurrence of an inward current in a percentage of
neurones similar to the percentage responding to
hyperglycaemia with an outward current. Acute
hypoglycaemia also altered the amplitude of electrically
evoked currents such that the paired-pulse ratio was
altered, while the amplitude of the current induced by
local application of muscimol was not. Overall these data
suggest that hypoglycaemia induced at the level of the
DMV membrane also acts via a presynaptic site of action.
These in vitro observations therefore support the in vivo
data that suggest that NTS neurones tonically inhibit the
activity of DMV neurones (Sivarao et al. 1998; Ferreira,
2000).
Even though these studies cannot determine the exact
site of action where glucose affects DMV neurones, our
data with picrotoxin suggest that a major part of the
effect of glucose is to excite a neuronal projection, maybe
from the NTS, to the DMV, that releases GABA (McCann
& Rogers, 1994). Similar effects of changes in glucose
concentration in the brain to release GABA have been
demonstrated by several investigators. For example,
Amoroso et al. (1990) reported that exposure of substantia
nigra slices to glucose increased GABA release. Similarly,
During et al. (1995) reported that glucose perfusion of the
substantia nigra in vivo increased GABA release. 
The mechanism responsible for glucose-induced GABA
release has been hypothesized to be through ATP-
dependent potassium channels (KATP channels) (Amoroso
et al. 1990; During et al. 1995; Levin et al. 1999). Glucose
is proposed to act as a signalling molecule to close the KATP
channels resulting in a slight depolarization which, in
turn, leads to the activation of Ca2+ and Na+ channels,
followed by full depolarization of the neurone. Evidence
that KATP channels were involved in glucose-evoked
responses in the present study is twofold. First, the
perfusion of the slice with the KATP channel blocker
glibenclamide (Amoroso et al. 1990) mimicked the actions
of glucose on evoked currents, as well as on the paired-
pulse response ratio. Second, perfusion of the slice with
the KATP channel opener diazoxide had the opposite effect
to glucose (and glibenclamide) on evoked currents.
Indeed, the effect of diazoxide on evoked currents was
similar to that observed by decreasing the normal glucose
concentration. 
Our data therefore imply that the responses obtained
with glucose in the brain slice preparation are presumably
due to actions of glucose on KATP channels of mNTS
neurones. In further support of this conclusion, no
differences were observed in the current amplitude
between experiments conducted in whole-cell recording
or in the perforated-patch recording configuration. ATP
is routinely included in the patch-pipette solution during
whole-cell recordings (to avoid run down of second-
messenger-mediated responses), but its addition is not
necessary in the perforated-patch configuration (where
there is no exchange of large intracellular components
between the cell and the recording pipette). Since ATP
closes KATP channels, the fact that no differences were
observed in these two configurations argues in favour of
an effect of glucose on cells other than the ones on which
the recording is made.
Since KATP channels have been hypothesized to be the
underlying mechanism responsible for the behaviour of
‘glucose-responsive’ (GR) neurones (Levin et al. 1999), we
suggest that the glucose-induced inhibition of gastric
motility noted in our study is due to increased firing of
GR GABAergic neurones in the mNTS that, in turn,
inhibit DMV neurones projecting to the phasically
contracting antrum. Furthermore, KATP channels appear
to be responsible for the excitatory effects of elevated
glucose on NTS neurones (Dallaporta et al. 2000), the
majority of which were also activated by the
sulphonylurea drugs tolbutamide and glibenclamide, and
were inhibited by the KATP channel opener pinacidil. 
In terms of extrapolating our data obtained with wide
ranging concentrations of glucose to animals that are
euglycaemic, hypoglycaemic and hyperglycaemic,
euglycaemia in the rat is considered to be approximately
5.9 mM (Borg et al. 1994), and the extremes of plasma
glucose in this species range from approximately 2.5 mM
(Borg et al. 1994) to approximately 22.2 mM (Thomson et
al. 2001). Our brain slice studies were conducted using
glucose concentrations of 2.5 mM (hypoglycaemia), 5 mM
(euglycaemia), and 11, 15 and 30 mM (hyperglycaemia).
Except for the 30 mM concentration of glucose, our
experimental conditions parallel the conditions tolerated
by the rat in studies of the physiological effects of hypo-
and hyperglycaemia. In our in vivo study, we micro-
injected 60 nl of a solution of either 10 or 50 mM of glucose
into brainstem nuclei. The experimental conditions using
10 mM glucose agree with concentrations used by other
investigators to study the effects of high blood-glucose
levels on brain function (e.g. Silver & Erecinska, 1994).
Since drugs applied locally to brain tissue diffuse and
equilibrate, the tissue concentration is actually
severalfold lower than the amount initially administered
(Fu et al. 1999). Hence, although 60 nl of 50 mM glucose
was microinjected, the actual tissue concentration of
glucose was severalfold less, and was probably in the
range compatible with an extreme hyperglycaemic state.
Conclusions
In conclusion, we have shown that acute hyperglycaemia
affects the central components of vago-vagal reflexes by
inducing a decrease in gastric motility and an increase in
intragastric pressure. The combined results of our in vivo
and in vitro studies suggest that these effects may be
mediated by an increase of GABA release from the mNTS
to gastric-projecting neurones of the DMV. In contrast to
previous studies in this area, our results implicate the
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mNTS, rather than the DMV, as the major glucose-
responsive area of the dorsal vagal complex. Further
studies will be necessary to confirm this conclusion, and to
identify the specific GR NTS cells responsible for these
effects, including the possibility that separate
populations of NTS cells may be responsible for the
decrease in motility versus the increase in intragastric
pressure. 
ADACHI, A., KOBASHI, M. & FUNAHASHI, M. (1995). Glucose-
responsive neurons in the brainstem. Obesity Research 3, suppl. 5,
7355–7405.
ALTSCHULER, S. M., BAO, X., BIEGER, D., HOPKINS, D. A. & MISELIS,
R. R. (1989). Viserotopic representation of the upper alimentary
tract in the rat: sensory ganglia and nuclei of the solitary and
spinal trigeminal tracts. Journal of Comparative Neurology 283,
248–268.
AMOROSO, S., SCHMID-ANTOMARCHI, H., FOSSET, M. & LAZDUNSKI, M.
(1990). Glucose, sulfonylureas and neurotransmitter release: role
of ATP-sensitive K+ channels. Science 247, 852–854.
BARNETT, J. L. & OWYANG, C. (1988). Serum glucose concentration as
a modulator of interdigestive gastric motility. Gastroenterology 94,
939–944.
BERTOLINO, M., VICINI, S., GILLIS, R. A. & TRAVAGLI, R. A. (1997).
Presynaptic a2-adrenoreceptors inhibit excitatory synaptic
transmission in rat brain. American Journal of Physiology 272,
G654–661.
BJORNSSON, E. S., URBANOVICIUS, V., ELIASSON, B., ATTRALL, S.,
SMITH, U. & ABRAHAMSSON, H. (1994). Effects of hyperglycemia on
gastrointestinal motility in humans. Scandinavian Journal of
Gastroenterology 29, 1096–1104.
BLESSING, W. W., LI, Y. W. & WESSELINGH, S. L. (1991).
Transneuronal transport of herpes simplex virus from the cervical
vagus to brain neurons with axonal inputs to central vagal
sensory nuclei in the rat. Neuroscience 42, 261–274.
BORG, W. P., DURING, M. J., SHERWIN, R. S., BORG, M. A., BRINES,
M. L. & SHULMAN, G. I. (1994) .Ventromedial hypothalamic lesions
in rats suppress counterregulatory responses to hypoglycemia.
Journal of Clinical Investigation 93, 1677–1682.
BROWNING, K. N., RENEHAN, W. E. & TRAVAGLI, R. A. (1999).
Electrophysiological and morphological heterogeneity of rat
dorsal vagal neurons which project to specific areas of the
gastrointestinal tract. Journal of Physiology 517, 521–532.
BROWNING, K. N. & TRAVAGLI, R. A. (1999). Characterization of the
in vitro effects of 5-hydroxytryptamine (5-HT) on identified
neurones of the rat dorsal motor nucleus of the vagus (DMV).
British Journal of Pharmacology 128, 1307–1315.
CLOUSE, R. E. & LUSTMAN P. J. (1989). Gastrointestinal symptoms in
diabetic patients: lack of association with neuropathy. American
Journal of Gastroenterology 8, 868–872.
DELLAPORTA, M., HIMMI, T., PERRIN, J. & ORSINI, J. C. (1999).
Solitary tract nucleus sensitivity to moderate changes in glucose
level. NeuroReport 10, 2657–2660.
DELLAPORTA, M., PERRIN, J. & ORSINI, J. C. (2000). Involvement of
adenosine triphosphate-sensitive K+ channels in glucose-sensing
in the rat solitary nucleus. Neuroscience 278, 77–80.
DURING, M. J., LEONE, P., DAVIS, K. E., KERR, D. & SHERWIN, R. S.
(1995). Glucose modulates rat substantia nigra GABA release in
vivo via ATP-sensitive potassium channels. Journal of Clinical
Investigation 95, 2403–2408.
ENCK, P., RATHMANN, W., SPIEKERMANN, M., CZERNER, D.,
TSCHOPE, D., ZIEGLER, D., STROHMEYER, G. & GRIES, F. A. (1994).
Prevalence of gastrointestinal symptoms in diabetic patients and
non-diabetic subjects. Zeitschrift fur Gastroenterologie 32,
637–641.
FELDMAN, M. & SCHILLER, L. R. (1983). Disorders of gastrointestinal
motility associated with diabetes mellitus. Annals of Internal
Medicine 98, 378–384.
FENG, H. S., LYNN, R. B., HANN, J. & BROOKS, F. P. (1990). Gastric
effects of TRH analog and bicuculline injected into the dorsal
motor nucleus in cats. American Journal of Physiology 259,
G321–327.
FERREIRA, M. F. (2000). Identification and characterization of
nAChRs in the brainstem of the rat that influence
gastrointestinal and cardiovascular function. PhD Thesis,
Department of Pharmacology at Georgetown University School of
Medicine, Washington.
FERREIRA, M. F., SINGH, A., DRETCHEN, K. L., KELLAR, K. J. &
GILLIS, R. A. (2000). Brainstem nicotinic receptor subtypes that
influence intragastric and arterial blood pressures. Journal of
Pharmacology and Experimental Therapeutics 294, 230–238.
FU, Y., MATTA, S. G. & SHARP, B. M. (1999). Local alpha-
bungarotoxin-sensitive nicotinic receptors modulate hippocampal
norepinephrine release by systemic nicotine. Journal of
Pharmacology and Experimental Therapeutics 289, 133–139.
HOROWITZ, M., HARDING, P. E., MADDOX, A. F., MADDERN, G. J. &
COLLINS, P. J. (1986). Gastric and oesophageal emptying in insulin-
dependant diabetes mellitus. Journal of Gastroenterology and
Hepatology 1, 97–113.
HOROWITZ, M., MADDOX, A. F., WISHART, J. M., HARDING, P. E.,
CHATTERTON, B. E. & SHEARMAN, D. J. (1991). Relationships
between oesophageal transit and solid and liquid gastric emptying
in diabetes mellitus. European Journal of Nuclear Medicine 18,
229–234.
JANATUINEN, E., PIKKARAINEN, P., LAAKSO, M. & PYORALA, K.
(1993). Gastrointestinal symptoms in middle-aged diabetic
patients. Scandinavian Journal of Gastroenterology 28, 427–432.
LEVIN, B. E., DUNN-MEYNELL, A. A. & ROUTH, V. H. (1999). Brain
glucose sensing and body energy homeostasis: role in obesity and
diabetes. American Journal of Physiology 276, R1223–1231.
KROWICKI, Z. K. & HORNBY, P. J. (1996). Contribution of
actetylcholine, vasoactive intestinal polypeptide and nitric oxide
to CNS-evoked vagal gastric relaxation in the rat.
Neurogastroenterology 8, 307–317.
MCCANN, M. J. & ROGERS, R. C. (1994). Functional and chemical
anatomy of gastric vago-vagal reflex. In Innervation of the Gut.
Pathophysiological Implications, chap. 6, ed. TACHE, Y., WINGATE,
D. L. & BURKS, T. F., pp. 81–92. CRC Press, Boca Raton.
MALEKI, D., LOCKE, G. R., CAMILLERI, M., ZINSMEISTER, A. R.,
YAWN, B. P., LEIBSON, C. & MELTON, L. J. (2000). Gastrointestinal
tract symptoms among persons with diabetes mellitus in the
community. Archives of Internal Medicine 160, 2808–2816.
MIZUNO, Y. & OOMURA, Y. (1984). Glucose responding neurons in the
nucleus tractus solitarius of the rat: in vitro study. Brain Research
307, 109–116.
NIIJIMA, A. (1969). Afferent impulse discharges from glucoreceptors
in the liver of the guinea pig. Annals of the New York Academy of
Sciences 157, 690–700.
Glucose effects in dorsal vagal complexJ. Physiol. 536.1 151
NIIJIMA, A. & MEQUID, M. M. (1994). Parenteral nutrients in rat
suppresses hepatic vagal afferent signals from portal vein to
hypothalamus. Surgery 116, 294–301.
PAXINOS, G. & WATSON, C. (1986) The Rat Brain in Stereotaxic
Coordinates. Academic Press, Sydney.
ROGERS, R. C., MCTIGUE, D. M. & HERMAN, G. E. (1995). Vagovagal
reflex control of digestion: afferent modulation by neural and
‘endoneurocrine’ factors. American Journal of Physiology 268,
G1–10.
SAKAGUCHI, T., OHTAKE, M. & YAMAZAKI, M. (1985). D-glucose
anomers in the nucleus of the vagus nerve can depress gastric
motility of rats. Brain Research 332, 390–393.
SAKAGUCHI, T., SANDOH, N. & AONO, T. (1994). Glucose signal in the
nucleus of the vagus nerve modulates the cyclicity of gastric
motility in rats. Brain Research 641, 163–166.
SAKAGUCHI, T. & SATO, Y. (1987). D-glucose anomers in the nucleus
of the tractus solitarius can reduce gastric acid secretion of rats.
Experimental Neurology 95, 525–529.
SAKAGUCHI, T. & SHIMOJO, E. (1984). Inhibition of gastric motility
induced by hepatic portal injections of D-glucose and its anomers.
Journal of Physiology 351, 573–581.
SAMPSON, M. J., WILSON, S., KARAGIANNIS, P., EDMONDS, M. &
WATKINS, P. J. (1990). Progression of diabetic autonomic
neuropathy over a decade in insulin-dependent diabetics.
Quarterly Journal of Medicine 75, 635–646. 
SILVER, I. A. & ERECINSKA, M. (1994). Extracellular glucose
concentration in mammalian brain: continuous monitoring of
changes during increased neuronal activity and upon limitation in
oxygen supply in normo-, hypo-, and hyperglycemic animals.
Journal of Neuroscience 14, 5068–5076.
SIVARAO, D. V., KROWICKI, Z. K. & HORNBY, P. J. (1998). Role of
GABAA receptors in rat hindbrain nuclei controlling gastric motor
function. Neurogastroenterology and Motility 10, 305–313.
SPRUSTON, N. & JOHNSTON, D. (1992). Perforated patch-clamp
analysis of the passive membrane properties of three classes of
hippocampal neurons. Journal of Neurophysiology 67, 508–529.
SYKES, R. M., SPYER, K. M. & IZZO, P. N. (1997). Demonstration of
glutamate immunoreactivity in vagal sensory afferents in the
nucleus tractus solitarius of the rat. Brain Research 762, 1–11.
THOMSON, S. C., DENG, A., BAO, D., SATRIANO, J., BLANTZ, R. C. &
VALLON, V. (2001). Ornithine decarboxylase, kidney size, and the
tubular hypothesis of glomerular hyperfiltration in experimental
diabetes. Journal of Clinical Investestigation 107, 217–224.
TRAVAGLI, R. A., GILLIS, R. A., ROSSITER, C. D. & VICINI, S. (1991).
Glutamate and GABA-mediated synaptic currents in neurons of
the rat dorsal motor nucleus of the vagus. American Journal of
Physiology 260, G531–536. 
TRAVAGLI, R. A. & WILLIAMS, J. T. (1996). Endogenous monoamines
inhibit glutamate transmission in the spinal trigeminal nucleus of
the guinea-pig. Journal of Physiology 491, 177–185.
TROMBLEY, P. Q. & WESTBROOK, G. L. (1990). Excitatory synaptic
transmission in cultures of rat olfactory bulb. Journal of
Neurophysiology 64, 598–606.
VINIK, A. I. & SUWANWALAIKORN, S. (1997). Autonomic
neuropathy. In Current Therapy of Diabetes Mellitus, ed.
DEFRONZO, R., pp. 165–176. Mosby-Year Book, St Louis, MO,
USA.
WASHABAN, R. J., FUDGE, M., PRICE, W. J. & BARONE, F. C. (1995).
GABA receptors in the dorsal motor nucleus of the vagus
influence feline lower esophageal sphincter and gastric function.
Brain Research Bulletin 38, 587–594.
WEGENER, M., BORSCH, G., SCHAFFSTEIN, J., LUERWEG, C. &
LEVERKUS, F. (1990). Gastrointestinal transit disorders in patients
with insulin-treated diabetes mellitus. Digestive Diseases 8, 23–36.
YAMANO, M., KAMATO, T., NAGAKURA, Y. & MIYOTA, K. (1997).
Effects of gastrokinetic agents on gastroparesis in streptozotocin-
induced diabetic rats. Naunyn-Schmiedeberg’s Archives of
Pharmacology 356, 145–150.
YETTEFTI, K., ORSINI, J. C., OUAZZANI, T. EI., HIMMI, T., BOYER, A.
& PERRIN, J. (1995). Sensitivity of nucleus tractus solitarius
neurons to induced moderate hyperglycemia, with special
reference to catecholaminergic regions. Journal of the Autonomic
Nervous System 51, 191–197. 
Acknowledgements
This work was supported by National Institutes of Health Grant
RO1 DK57105–01 (R.A.G.).
Manuel Ferreira Jr and Kirsteen N. Browning contributed equally to
the study.
Corresponding author
R. A. Gillis: Department of Pharmacology, Georgetown University
Medical Center, Washington, DC 20007, USA.
Email: gillisr@georgetown.edu
M. Ferreira Jr and others152 J. Physiol. 536.1
